Report Detail
Global Oncology Drug Market Research Report 2019
- RnM3143980 |
- 04 August, 2020 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Oncology Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oncology Drug market is segmented into
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
Segment by Application, the Oncology Drug market is segmented into
Blood Cancer
Breast Cancer
gastrointestinal Tract Cancer
Prostate Cancer
Lung Cancer
Skin Cancer
Regional and Country-level Analysis
The Oncology Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oncology Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oncology Drug Market Share Analysis
Oncology Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oncology Drug business, the date to enter into the Oncology Drug market, Oncology Drug product introduction, recent developments, etc.
The major vendors covered:
Roche Ltd
Novartis AG
Bristol-Myers Squibb
Celgene Corporation
Johnson & Johnson
Pfizer Inc.
Astra Zenca Plc
Eli Lilly And Company.
Glaxosmithkline Plc
Merck & Co.
Sanofi
Amgen Inc.
Abbvie
1 Study Coverage
- 1.1 Oncology Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Oncology Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Oncology Drug Market Size Growth Rate by Type
- 1.4.2 Chemotherapy
- 1.4.3 Targeted Therapy
- 1.4.4 Immunotherapy
- 1.4.5 Hormonal Therapy
- 1.4.6 Others
- 1.5 Market by Application
- 1.5.1 Global Oncology Drug Market Size Growth Rate by Application
- 1.5.2 Blood Cancer
- 1.5.3 Breast Cancer
- 1.5.4 gastrointestinal Tract Cancer
- 1.5.5 Prostate Cancer
- 1.5.6 Lung Cancer
- 1.5.7 Skin Cancer
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Oncology Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Oncology Drug Revenue 2015-2026
- 2.1.2 Global Oncology Drug Sales 2015-2026
- 2.2 Global Oncology Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Oncology Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Oncology Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oncology Drug Competitor Landscape by Players
- 3.1 Oncology Drug Sales by Manufacturers
- 3.1.1 Oncology Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Oncology Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Oncology Drug Revenue by Manufacturers
- 3.2.1 Oncology Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Oncology Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Oncology Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Oncology Drug Revenue in 2019
- 3.2.5 Global Oncology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Oncology Drug Price by Manufacturers
- 3.4 Oncology Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Oncology Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Oncology Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Oncology Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Oncology Drug Market Size by Type (2015-2020)
- 4.1.1 Global Oncology Drug Sales by Type (2015-2020)
- 4.1.2 Global Oncology Drug Revenue by Type (2015-2020)
- 4.1.3 Oncology Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Oncology Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Oncology Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Oncology Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Oncology Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Oncology Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Oncology Drug Market Size by Application (2015-2020)
- 5.1.1 Global Oncology Drug Sales by Application (2015-2020)
- 5.1.2 Global Oncology Drug Revenue by Application (2015-2020)
- 5.1.3 Oncology Drug Price by Application (2015-2020)
- 5.2 Oncology Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Oncology Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Oncology Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Oncology Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Oncology Drug by Country
- 6.1.1 North America Oncology Drug Sales by Country
- 6.1.2 North America Oncology Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Oncology Drug Market Facts & Figures by Type
- 6.3 North America Oncology Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Oncology Drug by Country
- 7.1.1 Europe Oncology Drug Sales by Country
- 7.1.2 Europe Oncology Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Oncology Drug Market Facts & Figures by Type
- 7.3 Europe Oncology Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Oncology Drug by Region
- 8.1.1 Asia Pacific Oncology Drug Sales by Region
- 8.1.2 Asia Pacific Oncology Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Oncology Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Oncology Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Oncology Drug by Country
- 9.1.1 Latin America Oncology Drug Sales by Country
- 9.1.2 Latin America Oncology Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Oncology Drug Market Facts & Figures by Type
- 9.3 Central & South America Oncology Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Oncology Drug by Country
- 10.1.1 Middle East and Africa Oncology Drug Sales by Country
- 10.1.2 Middle East and Africa Oncology Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Oncology Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Oncology Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Roche Ltd
- 11.1.1 Roche Ltd Corporation Information
- 11.1.2 Roche Ltd Description and Business Overview
- 11.1.3 Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Roche Ltd Oncology Drug Products Offered
- 11.1.5 Roche Ltd Related Developments
- 11.2 Novartis AG
- 11.2.1 Novartis AG Corporation Information
- 11.2.2 Novartis AG Description and Business Overview
- 11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Novartis AG Oncology Drug Products Offered
- 11.2.5 Novartis AG Related Developments
- 11.3 Bristol-Myers Squibb
- 11.3.1 Bristol-Myers Squibb Corporation Information
- 11.3.2 Bristol-Myers Squibb Description and Business Overview
- 11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bristol-Myers Squibb Oncology Drug Products Offered
- 11.3.5 Bristol-Myers Squibb Related Developments
- 11.4 Celgene Corporation
- 11.4.1 Celgene Corporation Corporation Information
- 11.4.2 Celgene Corporation Description and Business Overview
- 11.4.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Celgene Corporation Oncology Drug Products Offered
- 11.4.5 Celgene Corporation Related Developments
- 11.5 Johnson & Johnson
- 11.5.1 Johnson & Johnson Corporation Information
- 11.5.2 Johnson & Johnson Description and Business Overview
- 11.5.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Johnson & Johnson Oncology Drug Products Offered
- 11.5.5 Johnson & Johnson Related Developments
- 11.6 Pfizer Inc.
- 11.6.1 Pfizer Inc. Corporation Information
- 11.6.2 Pfizer Inc. Description and Business Overview
- 11.6.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Pfizer Inc. Oncology Drug Products Offered
- 11.6.5 Pfizer Inc. Related Developments
- 11.7 Astra Zenca Plc
- 11.7.1 Astra Zenca Plc Corporation Information
- 11.7.2 Astra Zenca Plc Description and Business Overview
- 11.7.3 Astra Zenca Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Astra Zenca Plc Oncology Drug Products Offered
- 11.7.5 Astra Zenca Plc Related Developments
- 11.8 Eli Lilly And Company.
- 11.8.1 Eli Lilly And Company. Corporation Information
- 11.8.2 Eli Lilly And Company. Description and Business Overview
- 11.8.3 Eli Lilly And Company. Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Eli Lilly And Company. Oncology Drug Products Offered
- 11.8.5 Eli Lilly And Company. Related Developments
- 11.9 Glaxosmithkline Plc
- 11.9.1 Glaxosmithkline Plc Corporation Information
- 11.9.2 Glaxosmithkline Plc Description and Business Overview
- 11.9.3 Glaxosmithkline Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Glaxosmithkline Plc Oncology Drug Products Offered
- 11.9.5 Glaxosmithkline Plc Related Developments
- 11.10 Merck & Co.
- 11.10.1 Merck & Co. Corporation Information
- 11.10.2 Merck & Co. Description and Business Overview
- 11.10.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Merck & Co. Oncology Drug Products Offered
- 11.10.5 Merck & Co. Related Developments
- 11.1 Roche Ltd
- 11.1.1 Roche Ltd Corporation Information
- 11.1.2 Roche Ltd Description and Business Overview
- 11.1.3 Roche Ltd Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Roche Ltd Oncology Drug Products Offered
- 11.1.5 Roche Ltd Related Developments
- 11.12 Amgen Inc.
- 11.12.1 Amgen Inc. Corporation Information
- 11.12.2 Amgen Inc. Description and Business Overview
- 11.12.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Amgen Inc. Products Offered
- 11.12.5 Amgen Inc. Related Developments
- 11.13 Abbvie
- 11.13.1 Abbvie Corporation Information
- 11.13.2 Abbvie Description and Business Overview
- 11.13.3 Abbvie Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Abbvie Products Offered
- 11.13.5 Abbvie Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Oncology Drug Market Estimates and Projections by Region
- 12.1.1 Global Oncology Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Oncology Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Oncology Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Oncology Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Oncology Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Oncology Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Oncology Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Oncology Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Oncology Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Oncology Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Oncology Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Oncology Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Oncology Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Oncology Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Oncology Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Oncology Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Oncology Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Oncology Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Oncology Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Oncology Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Oncology Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Oncology Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Oncology Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Oncology Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Oncology Drug. Industry analysis & Market Report on Oncology Drug is a syndicated market report, published as Global Oncology Drug Market Research Report 2019. It is complete Research Study and Industry Analysis of Oncology Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
